These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 25616667)

  • 1. Genetic variants are major determinants of CSF antibody levels in multiple sclerosis.
    Goris A; Pauwels I; Gustavsen MW; van Son B; Hilven K; Bos SD; Celius EG; Berg-Hansen P; Aarseth J; Myhr KM; D'Alfonso S; Barizzone N; Leone MA; Martinelli Boneschi F; Sorosina M; Liberatore G; Kockum I; Olsson T; Hillert J; Alfredsson L; Bedri SK; Hemmer B; Buck D; Berthele A; Knier B; Biberacher V; van Pesch V; Sindic C; Bang Oturai A; Søndergaard HB; Sellebjerg F; Jensen PE; Comabella M; Montalban X; Pérez-Boza J; Malhotra S; Lechner-Scott J; Broadley S; Slee M; Taylor B; Kermode AG; Gourraud PA; ; Sawcer SJ; Andreassen BK; Dubois B; Harbo HF
    Brain; 2015 Mar; 138(Pt 3):632-43. PubMed ID: 25616667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of HLA DRB1 alleles with IgG oligoclonal bands and their influence on multiple sclerosis course and disability status.
    Balnytė R; Rastenytė D; Vaitkus A; Skrodenienė E; Vitkauskienė A; Ulozienė I
    Medicina (Kaunas); 2016; 52(4):217-222. PubMed ID: 27515835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new risk variant for multiple sclerosis at the immunoglobulin heavy chain locus associates with intrathecal IgG, IgM index and oligoclonal bands.
    Delgado-García M; Matesanz F; Alcina A; Fedetz M; García-Sánchez MI; Ruiz-Peña JL; Fernández Ó; Pinto Medel MJ; Leyva L; Arnal C; Delgado C; López Guerrero JA; González-Pérez A; Sáez ME; Villar LM; Álvarez-Cermeño JC; Picón C; Arroyo R; Varadé J; Urcelay E; Izquierdo G; Lucas M
    Mult Scler; 2015 Aug; 21(9):1104-11. PubMed ID: 25392328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Persisting Significance of Oligoclonal Bands in the Dawning Era of Kappa Free Light Chains for the Diagnosis of Multiple Sclerosis.
    Schwenkenbecher P; Konen FF; Wurster U; Jendretzky KF; Gingele S; Sühs KW; Pul R; Witte T; Stangel M; Skripuletz T
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30501024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of HLA DRB1*1501 and oligoclonal bands in multiple sclerosis: clinical features and disability.
    Balnytė R; Rastenytė D; Ulozienė I; Mickevičienė D; Skordenienė E; Vitkauskienė A
    Medicina (Kaunas); 2011; 47(7):368-73. PubMed ID: 22112985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latitude and HLA-DRB1 alleles independently affect the emergence of cerebrospinal fluid IgG abnormality in multiple sclerosis.
    Niino M; Sato S; Fukazawa T; Yoshimura S; Hisahara S; Matsushita T; Isobe N; Yoshida K; Houzen H; Miyazaki Y; Shimohama S; Kikuchi S; Kira J
    Mult Scler; 2015 Aug; 21(9):1112-20. PubMed ID: 25583844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis.
    Harbo HF; Isobe N; Berg-Hansen P; Bos SD; Caillier SJ; Gustavsen MW; Mero IL; Celius EG; Hauser SL; Oksenberg JR; Gourraud PA
    Mult Scler; 2014 May; 20(6):660-8. PubMed ID: 24099750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated antibody reactivity to measles virus NCORE protein among patients with multiple sclerosis and their healthy siblings with intrathecal oligoclonal immunoglobulin G production.
    Persson L; Longhi S; Enarsson J; Andersen O; Haghigi S; Nilsson S; Lagging M; Johansson M; Bergström T
    J Clin Virol; 2014 Sep; 61(1):107-12. PubMed ID: 25022622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The complex relationship between oligoclonal bands, lymphocytes in the cerebrospinal fluid, and immunoglobulin G antibodies in multiple sclerosis: Indication of serum contribution.
    Beseler C; Vollmer T; Graner M; Yu X
    PLoS One; 2017; 12(10):e0186842. PubMed ID: 29059249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of HLA-DRB1*15 allele and CSF oligoclonal bands in a Spanish multiple sclerosis cohort.
    Romero-Pinel L; Martínez-Yélamos S; Bau L; Matas E; Gubieras L; María Pujal J; Morandeira F; Bas J; Arbizu T
    Eur J Neurol; 2011 Oct; 18(10):1258-62. PubMed ID: 21418440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of natalizumab on oligoclonal bands in the cerebrospinal fluid of multiple sclerosis patients: a longitudinal study.
    Mancuso R; Franciotta D; Rovaris M; Caputo D; Sala A; Hernis A; Agostini S; Calvo M; Clerici M
    Mult Scler; 2014 Dec; 20(14):1900-3. PubMed ID: 24948690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid are less likely to develop neutralizing antibodies against interferon beta.
    Lundkvist M; Greiner E; Hillert J; Fogdell-Hahn A
    Mult Scler; 2010 Jul; 16(7):796-800. PubMed ID: 20534645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden of risk variants correlates with phenotype of multiple sclerosis.
    Hilven K; Patsopoulos NA; Dubois B; Goris A
    Mult Scler; 2015 Nov; 21(13):1670-80. PubMed ID: 25948629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles.
    Mero IL; Gustavsen MW; Sæther HS; Flåm ST; Berg-Hansen P; Søndergaard HB; Jensen PE; Berge T; Bjølgerud A; Muggerud A; Aarseth JH; ; Myhr KM; Celius EG; Sellebjerg F; Hillert J; Alfredsson L; Olsson T; Oturai AB; Kockum I; Lie BA; Andreassen BK; Harbo HF
    PLoS One; 2013; 8(3):e58352. PubMed ID: 23472185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of cerebrospinal fluid oligoclonal IgG bands in Greek patients with clinically isolated syndrome and multiple sclerosis.
    Andreadou E; Chatzipanagiotou S; Constantinides VC; Rombos A; Stamboulis E; Nicolaou C
    Clin Neurol Neurosurg; 2013 Oct; 115(10):2094-8. PubMed ID: 23953642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of intrathecal immunoglobulin G synthesis by capillary isoelectric focusing immunoassay in oligoclonal band negative multiple sclerosis.
    Halbgebauer S; Huss A; Buttmann M; Steinacker P; Oeckl P; Brecht I; Weishaupt A; Tumani H; Otto M
    J Neurol; 2016 May; 263(5):954-960. PubMed ID: 26995358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligoclonal bands.
    Willis MD; Kreft KL; Dancey B
    Pract Neurol; 2024 Sep; 24(5):400-406. PubMed ID: 38937092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid CXCL13 in clinically isolated syndrome patients: Association with oligoclonal IgM bands and prediction of Multiple Sclerosis diagnosis.
    Ferraro D; Galli V; Vitetta F; Simone AM; Bedin R; Del Giovane C; Morselli F; Filippini MM; Nichelli PF; Sola P
    J Neuroimmunol; 2015 Jun; 283():64-9. PubMed ID: 26004159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct.
    Imrell K; Landtblom AM; Hillert J; Masterman T
    Neurology; 2006 Sep; 67(6):1062-4. PubMed ID: 17000979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid oligoclonal bands and progression of disability in multiple sclerosis.
    Koch M; Heersema D; Mostert J; Teelken A; De Keyser J
    Eur J Neurol; 2007 Jul; 14(7):797-800. PubMed ID: 17594338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.